Handheld Ultrasound Market Forecasts to 2032 – Global Analysis By Transducer Type (Linear Array, Endocavity, Curved Array, Phased Array, and Other Scanners), Software & Connectivity, Data Management Features, Technology, Application, End User and By Geogr
Description
According to Stratistics MRC, the Global Handheld Ultrasound Market is accounted for $402.00 million in 2025 and is expected to reach $1037.22 million by 2032 growing at a CAGR of 14.5% during the forecast period. A handheld ultrasound is a small, portable imaging tool designed to capture live visuals of organs, tissues, and circulation using sound waves. Unlike conventional ultrasound systems, it is compact, highly mobile, and convenient for use in bedside examinations or field conditions. Offering rapid diagnostic insights, it supports healthcare providers in immediate clinical assessments. Its versatility makes it valuable in emergency medicine, intensive care, and frontline healthcare, improving accessibility to essential diagnostic imaging.
According to data published by the World Health Organization (WHO), there were an estimated 20.0 million new cancer cases globally in 2022.
Market Dynamics:
Driver:
Rising prevalence of chronic diseases
The growing burden of chronic illnesses such as cardiovascular disease, diabetes, and cancer is fueling demand for portable diagnostic solutions. Handheld ultrasound devices are increasingly used for point-of-care imaging to support early detection and ongoing monitoring. As global populations age, healthcare systems are shifting toward proactive and personalized care models. These compact imaging tools enable clinicians to perform bedside assessments, reducing the need for costly and time-consuming referrals. Technological advancements in probe miniaturization and AI-powered image interpretation are enhancing diagnostic accuracy. The trend toward decentralized healthcare is accelerating the adoption of handheld ultrasound across hospitals, clinics, and home settings.
Restraint:
Limited image quality and advanced features
Limitations in processing power and transducer capabilities restrict their use in complex diagnostic scenarios. Advanced features like elastography, Doppler imaging, and 3D reconstruction are still underdeveloped in many handheld models. These constraints can hinder clinical decision-making, especially in high-stakes environments like emergency rooms or surgical suites. Manufacturers face challenges in balancing compact design with high-performance imaging. As a result, adoption may be slower in specialties that demand precision and comprehensive visualization.
Opportunity:
Integration with telemedicine and remote patient monitoring
The convergence of handheld ultrasound with telehealth platforms is opening new frontiers in remote diagnostics. Physicians can now guide scans in real-time and interpret images from afar, improving access in underserved regions. Integration with cloud-based systems allows seamless data sharing and longitudinal patient tracking. Emerging trends include AI-assisted image analysis and smartphone-connected probes that enhance usability for non-specialists. These innovations are particularly valuable in home healthcare, rural clinics, and disaster response scenarios. As virtual care becomes mainstream, handheld ultrasound is poised to become a cornerstone of remote patient monitoring ecosystems.
Threat:
Data security and privacy concerns
The digitization of ultrasound imaging raises significant concerns around patient data protection. Wireless transmission and cloud storage expose sensitive health information to potential breaches. Compliance with regulations such as HIPAA and GDPR requires robust encryption and secure access protocols. Smaller manufacturers may struggle to implement enterprise-grade cybersecurity measures, increasing vulnerability. The integration of AI and IoT further complicates data governance, especially when third-party platforms are involved. Without stringent safeguards, trust in handheld ultrasound technology could be undermined, slowing its adoption in clinical workflows.
Covid-19 Impact:
The COVID-19 pandemic accelerated the use of handheld ultrasound for rapid bedside assessments, especially in respiratory and cardiac evaluations. Hospitals prioritized portable imaging to minimize patient movement and reduce cross-contamination risks. Supply chain disruptions initially hampered device availability, but demand surged as clinicians sought flexible diagnostic tools. Regulatory bodies responded with expedited approvals and emergency use authorizations to support frontline care. The crisis also catalyzed innovation in wireless probes and AI-guided scanning for non-radiologists. Post-pandemic, handheld ultrasound is increasingly viewed as an essential tool for resilient and scalable healthcare delivery.
The linear arraysegment is expected to be the largest during the forecast period
The linear array segment is expected to account for the largest market share during the forecast period, due to its versatility in vascular, musculoskeletal, and superficial organ imaging. These probes offer high-resolution imaging for surface-level diagnostics, making them indispensable in emergency and outpatient settings. Advancements in beamforming and signal processing are improving clarity and diagnostic confidence. Integration with mobile platforms enables real-time sharing and annotation of images. The segment benefits from rising demand in sports medicine, anesthesiology, and trauma care. As clinical applications expand, linear array probes continue to lead in both volume and innovation.
The home healthcare segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate, driven by the shift toward decentralized care. Patients and caregivers are increasingly empowered to perform basic scans under remote supervision. Compact, user-friendly devices with AI guidance are making ultrasound accessible beyond clinical environments. The rise of chronic disease management and aging populations is fueling demand for in-home diagnostics. Integration with wearable sensors and telehealth platforms is enhancing continuity of care. As reimbursement models evolve to support remote services, home-based ultrasound is becoming a key enabler of personalized medicine.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, supported by expanding healthcare infrastructure and rising diagnostic demand. Countries like China, India, and Japan are investing in portable imaging to bridge gaps in rural and urban care. Government initiatives promoting digital health and local manufacturing are boosting device penetration. The region is witnessing rapid adoption of AI-enabled ultrasound and smartphone-integrated probes. Strategic collaborations between global OEMs and regional startups are accelerating innovation and affordability. With a growing middle class and increasing healthcare awareness, Asia Pacific remains a powerhouse for handheld ultrasound growth.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by technological leadership and robust R&D investment. The U.S. and Canada are pioneering smart ultrasound systems with AI diagnostics and cloud connectivity. Hospitals are integrating handheld devices into electronic health records and remote care platforms. Regulatory agencies are streamlining approvals for next-gen imaging tools, encouraging rapid commercialization. The region benefits from strong reimbursement policies and high adoption of point-of-care technologies. As precision diagnostics gain momentum, North America continues to set the benchmark for handheld ultrasound innovation.
Key players in the market
Some of the key players in Handheld Ultrasound Market include GE HealthCare Technologies Inc., Healcerion Co., Ltd., Siemens Healthineers AG, EchoNous Inc., Koninklijke Philips N.V., Aco Healthcare Co., Ltd., Canon Medical Systems Corporation, DGH Technology, Inc., FUJIFILM Holdings Corporation, Dawei Group, Mindray Medical International Ltd., BMV AG, Butterfly Network Inc., CHISON Medical Technologies Co., Ltd., and Clarius Mobile Health Corp.
Key Developments:
In September2025, GE HealthCare announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning.
In September2025, FUJIFILM Biotechnologies announced a significant expansion of its global partnership with argenx SE, a global immunology company. As part of the expanded agreement, FUJIFILM Biotechnologies will initiate manufacturing of argenx’ drug substance for efgartigimod at the Holly Springs, North Carolina, site in 2028.
TransducerTypes Covered:
• Linear Array
• Endocavity
• Curved Array
• Phased Array
• Other Scanners
Software &ConnectivitiesCovered:
• Smartphone Application-Based Devices
• Customized Software-Based Scanners
• Bluetooth
• USB Connectivity
• Wi-Fi / Cellular
Data Management FeaturesCovered:
• Internal Storage
• External Storage
• Cloud / Remote Monitoring
Technologies Covered:
• 2D Ultrasound
• 3D/4D Ultrasound
• Doppler Ultrasound
Applications Covered:
• Obstetrics &Gynecology (OBGY)
• Urology
• Cardiology
• Pulmonary
• Vascular Imaging
• Emergency Medicine
• Abdominal Imaging
• Musculoskeletal (MSK)
• Other Applications
End Users Covered:
• Hospitals
• Diagnostic Imaging Centers
• Home Healthcare
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Maternity Clinics
• Other End Users
Regions Covered:
• North America US Canada Mexico
• Europe Germany UK Italy France Spain Rest of Europe
• Asia Pacific Japan China India Australia New Zealand South Korea Rest of Asia Pacific
• South America Argentina Brazil Chile Rest of South America
• Middle East & Africa Saudi Arabia UAE Qatar South Africa Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
According to data published by the World Health Organization (WHO), there were an estimated 20.0 million new cancer cases globally in 2022.
Market Dynamics:
Driver:
Rising prevalence of chronic diseases
The growing burden of chronic illnesses such as cardiovascular disease, diabetes, and cancer is fueling demand for portable diagnostic solutions. Handheld ultrasound devices are increasingly used for point-of-care imaging to support early detection and ongoing monitoring. As global populations age, healthcare systems are shifting toward proactive and personalized care models. These compact imaging tools enable clinicians to perform bedside assessments, reducing the need for costly and time-consuming referrals. Technological advancements in probe miniaturization and AI-powered image interpretation are enhancing diagnostic accuracy. The trend toward decentralized healthcare is accelerating the adoption of handheld ultrasound across hospitals, clinics, and home settings.
Restraint:
Limited image quality and advanced features
Limitations in processing power and transducer capabilities restrict their use in complex diagnostic scenarios. Advanced features like elastography, Doppler imaging, and 3D reconstruction are still underdeveloped in many handheld models. These constraints can hinder clinical decision-making, especially in high-stakes environments like emergency rooms or surgical suites. Manufacturers face challenges in balancing compact design with high-performance imaging. As a result, adoption may be slower in specialties that demand precision and comprehensive visualization.
Opportunity:
Integration with telemedicine and remote patient monitoring
The convergence of handheld ultrasound with telehealth platforms is opening new frontiers in remote diagnostics. Physicians can now guide scans in real-time and interpret images from afar, improving access in underserved regions. Integration with cloud-based systems allows seamless data sharing and longitudinal patient tracking. Emerging trends include AI-assisted image analysis and smartphone-connected probes that enhance usability for non-specialists. These innovations are particularly valuable in home healthcare, rural clinics, and disaster response scenarios. As virtual care becomes mainstream, handheld ultrasound is poised to become a cornerstone of remote patient monitoring ecosystems.
Threat:
Data security and privacy concerns
The digitization of ultrasound imaging raises significant concerns around patient data protection. Wireless transmission and cloud storage expose sensitive health information to potential breaches. Compliance with regulations such as HIPAA and GDPR requires robust encryption and secure access protocols. Smaller manufacturers may struggle to implement enterprise-grade cybersecurity measures, increasing vulnerability. The integration of AI and IoT further complicates data governance, especially when third-party platforms are involved. Without stringent safeguards, trust in handheld ultrasound technology could be undermined, slowing its adoption in clinical workflows.
Covid-19 Impact:
The COVID-19 pandemic accelerated the use of handheld ultrasound for rapid bedside assessments, especially in respiratory and cardiac evaluations. Hospitals prioritized portable imaging to minimize patient movement and reduce cross-contamination risks. Supply chain disruptions initially hampered device availability, but demand surged as clinicians sought flexible diagnostic tools. Regulatory bodies responded with expedited approvals and emergency use authorizations to support frontline care. The crisis also catalyzed innovation in wireless probes and AI-guided scanning for non-radiologists. Post-pandemic, handheld ultrasound is increasingly viewed as an essential tool for resilient and scalable healthcare delivery.
The linear arraysegment is expected to be the largest during the forecast period
The linear array segment is expected to account for the largest market share during the forecast period, due to its versatility in vascular, musculoskeletal, and superficial organ imaging. These probes offer high-resolution imaging for surface-level diagnostics, making them indispensable in emergency and outpatient settings. Advancements in beamforming and signal processing are improving clarity and diagnostic confidence. Integration with mobile platforms enables real-time sharing and annotation of images. The segment benefits from rising demand in sports medicine, anesthesiology, and trauma care. As clinical applications expand, linear array probes continue to lead in both volume and innovation.
The home healthcare segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate, driven by the shift toward decentralized care. Patients and caregivers are increasingly empowered to perform basic scans under remote supervision. Compact, user-friendly devices with AI guidance are making ultrasound accessible beyond clinical environments. The rise of chronic disease management and aging populations is fueling demand for in-home diagnostics. Integration with wearable sensors and telehealth platforms is enhancing continuity of care. As reimbursement models evolve to support remote services, home-based ultrasound is becoming a key enabler of personalized medicine.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, supported by expanding healthcare infrastructure and rising diagnostic demand. Countries like China, India, and Japan are investing in portable imaging to bridge gaps in rural and urban care. Government initiatives promoting digital health and local manufacturing are boosting device penetration. The region is witnessing rapid adoption of AI-enabled ultrasound and smartphone-integrated probes. Strategic collaborations between global OEMs and regional startups are accelerating innovation and affordability. With a growing middle class and increasing healthcare awareness, Asia Pacific remains a powerhouse for handheld ultrasound growth.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by technological leadership and robust R&D investment. The U.S. and Canada are pioneering smart ultrasound systems with AI diagnostics and cloud connectivity. Hospitals are integrating handheld devices into electronic health records and remote care platforms. Regulatory agencies are streamlining approvals for next-gen imaging tools, encouraging rapid commercialization. The region benefits from strong reimbursement policies and high adoption of point-of-care technologies. As precision diagnostics gain momentum, North America continues to set the benchmark for handheld ultrasound innovation.
Key players in the market
Some of the key players in Handheld Ultrasound Market include GE HealthCare Technologies Inc., Healcerion Co., Ltd., Siemens Healthineers AG, EchoNous Inc., Koninklijke Philips N.V., Aco Healthcare Co., Ltd., Canon Medical Systems Corporation, DGH Technology, Inc., FUJIFILM Holdings Corporation, Dawei Group, Mindray Medical International Ltd., BMV AG, Butterfly Network Inc., CHISON Medical Technologies Co., Ltd., and Clarius Mobile Health Corp.
Key Developments:
In September2025, GE HealthCare announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning.
In September2025, FUJIFILM Biotechnologies announced a significant expansion of its global partnership with argenx SE, a global immunology company. As part of the expanded agreement, FUJIFILM Biotechnologies will initiate manufacturing of argenx’ drug substance for efgartigimod at the Holly Springs, North Carolina, site in 2028.
TransducerTypes Covered:
• Linear Array
• Endocavity
• Curved Array
• Phased Array
• Other Scanners
Software &ConnectivitiesCovered:
• Smartphone Application-Based Devices
• Customized Software-Based Scanners
• Bluetooth
• USB Connectivity
• Wi-Fi / Cellular
Data Management FeaturesCovered:
• Internal Storage
• External Storage
• Cloud / Remote Monitoring
Technologies Covered:
• 2D Ultrasound
• 3D/4D Ultrasound
• Doppler Ultrasound
Applications Covered:
• Obstetrics &Gynecology (OBGY)
• Urology
• Cardiology
• Pulmonary
• Vascular Imaging
• Emergency Medicine
• Abdominal Imaging
• Musculoskeletal (MSK)
• Other Applications
End Users Covered:
• Hospitals
• Diagnostic Imaging Centers
• Home Healthcare
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Maternity Clinics
• Other End Users
Regions Covered:
• North America US Canada Mexico
• Europe Germany UK Italy France Spain Rest of Europe
• Asia Pacific Japan China India Australia New Zealand South Korea Rest of Asia Pacific
• South America Argentina Brazil Chile Rest of South America
• Middle East & Africa Saudi Arabia UAE Qatar South Africa Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Table of Contents
200 Pages
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 Application Analysis
- 3.8 End User Analysis
- 3.9 Emerging Markets
- 3.10 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global Handheld Ultrasound Market, By Transducer Type
- 5.1 Introduction
- 5.2 Linear Array
- 5.3 Endocavity
- 5.4 Curved Array
- 5.5 Phased Array
- 5.6 Other Scanners
- 6 Global Handheld Ultrasound Market, By Software & Connectivity
- 6.1 Introduction
- 6.2 Smartphone Application-Based Devices
- 6.3 Customized Software-Based Scanners
- 6.4 Bluetooth
- 6.5 USB Connectivity
- 6.6 Wi-Fi / Cellular
- 7 Global Handheld Ultrasound Market, By Data Management Features
- 7.1 Introduction
- 7.2 Internal Storage
- 7.3 External Storage
- 7.4 Cloud / Remote Monitoring
- 8 Global Handheld Ultrasound Market, By Technology
- 8.1 Introduction
- 8.2 2D Ultrasound
- 8.3 3D/4D Ultrasound
- 8.4 Doppler Ultrasound
- 8.4.1 Color Doppler
- 8.4.2 Power Doppler
- 8.4.3 Tissue Harmonic Imaging
- 8.4.4 Pulsed Wave Doppler
- 9 Global Handheld Ultrasound Market, By Application
- 9.1 Introduction
- 9.2 Obstetrics & Gynecology (OBGY)
- 9.3 Urology
- 9.4 Cardiology
- 9.5 Pulmonary
- 9.6 Vascular Imaging
- 9.7 Emergency Medicine
- 9.8 Abdominal Imaging
- 9.9 Musculoskeletal (MSK)
- 9.10 Other Applications
- 10 Global Handheld Ultrasound Market, By End User
- 10.1 Introduction
- 10.2 Hospitals
- 10.3 Diagnostic Imaging Centers
- 10.4 Home Healthcare
- 10.5 Ambulatory Surgical Centers (ASCs)
- 10.6 Specialty Clinics
- 10.7 Maternity Clinics
- 10.8 Other End Users
- 11 Global Handheld Ultrasound Market, By Geography
- 11.1 Introduction
- 11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
- 11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 New Zealand
- 11.4.6 South Korea
- 11.4.7 Rest of Asia Pacific
- 11.5 South America
- 11.5.1 Argentina
- 11.5.2 Brazil
- 11.5.3 Chile
- 11.5.4 Rest of South America
- 11.6 Middle East & Africa
- 11.6.1 Saudi Arabia
- 11.6.2 UAE
- 11.6.3 Qatar
- 11.6.4 South Africa
- 11.6.5 Rest of Middle East & Africa
- 12 Key Developments
- 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 12.2 Acquisitions & Mergers
- 12.3 New Product Launch
- 12.4 Expansions
- 12.5 Other Key Strategies
- 13 Company Profiling
- 13.1 GE HealthCare Technologies Inc.
- 13.2 Healcerion Co., Ltd.
- 13.3 Siemens Healthineers AG
- 13.4 EchoNous Inc.
- 13.5 Koninklijke Philips N.V.
- 13.6 Aco Healthcare Co., Ltd.
- 13.7 Canon Medical Systems Corporation
- 13.8 DGH Technology, Inc.
- 13.9 FUJIFILM Holdings Corporation
- 13.10 Dawei Group
- 13.11 Mindray Medical International Ltd.
- 13.12 BMV AG
- 13.13 Butterfly Network Inc.
- 13.14 CHISON Medical Technologies Co., Ltd.
- 13.15 Clarius Mobile Health Corp.
- List of Tables
- Table 1 Global Handheld Ultrasound Market Outlook, By Region (2024-2032) ($MN)
- Table 2 Global Handheld Ultrasound Market Outlook, By Transducer Type (2024-2032) ($MN)
- Table 3 Global Handheld Ultrasound Market Outlook, By Linear Array (2024-2032) ($MN)
- Table 4 Global Handheld Ultrasound Market Outlook, By Endocavity (2024-2032) ($MN)
- Table 5 Global Handheld Ultrasound Market Outlook, By Curved Array (2024-2032) ($MN)
- Table 6 Global Handheld Ultrasound Market Outlook, By Phased Array (2024-2032) ($MN)
- Table 7 Global Handheld Ultrasound Market Outlook, By Other Scanners (2024-2032) ($MN)
- Table 8 Global Handheld Ultrasound Market Outlook, By Software & Connectivity (2024-2032) ($MN)
- Table 9 Global Handheld Ultrasound Market Outlook, By Smartphone Application-Based Devices (2024-2032) ($MN)
- Table 10 Global Handheld Ultrasound Market Outlook, By Customized Software-Based Scanners (2024-2032) ($MN)
- Table 11 Global Handheld Ultrasound Market Outlook, By Bluetooth (2024-2032) ($MN)
- Table 12 Global Handheld Ultrasound Market Outlook, By USB Connectivity (2024-2032) ($MN)
- Table 13 Global Handheld Ultrasound Market Outlook, By Wi-Fi / Cellular (2024-2032) ($MN)
- Table 14 Global Handheld Ultrasound Market Outlook, By Data Management Features (2024-2032) ($MN)
- Table 15 Global Handheld Ultrasound Market Outlook, By Internal Storage (2024-2032) ($MN)
- Table 16 Global Handheld Ultrasound Market Outlook, By External Storage (2024-2032) ($MN)
- Table 17 Global Handheld Ultrasound Market Outlook, By Cloud / Remote Monitoring (2024-2032) ($MN)
- Table 18 Global Handheld Ultrasound Market Outlook, By Technology (2024-2032) ($MN)
- Table 19 Global Handheld Ultrasound Market Outlook, By 2D Ultrasound (2024-2032) ($MN)
- Table 20 Global Handheld Ultrasound Market Outlook, By 3D/4D Ultrasound (2024-2032) ($MN)
- Table 21 Global Handheld Ultrasound Market Outlook, By Doppler Ultrasound (2024-2032) ($MN)
- Table 22 Global Handheld Ultrasound Market Outlook, By Color Doppler (2024-2032) ($MN)
- Table 23 Global Handheld Ultrasound Market Outlook, By Power Doppler (2024-2032) ($MN)
- Table 24 Global Handheld Ultrasound Market Outlook, By Tissue Harmonic Imaging (2024-2032) ($MN)
- Table 25 Global Handheld Ultrasound Market Outlook, By Pulsed Wave Doppler (2024-2032) ($MN)
- Table 26 Global Handheld Ultrasound Market Outlook, By Application (2024-2032) ($MN)
- Table 27 Global Handheld Ultrasound Market Outlook, By Obstetrics & Gynecology (OBGY) (2024-2032) ($MN)
- Table 28 Global Handheld Ultrasound Market Outlook, By Urology (2024-2032) ($MN)
- Table 29 Global Handheld Ultrasound Market Outlook, By Cardiology (2024-2032) ($MN)
- Table 30 Global Handheld Ultrasound Market Outlook, By Pulmonary (2024-2032) ($MN)
- Table 31 Global Handheld Ultrasound Market Outlook, By Vascular Imaging (2024-2032) ($MN)
- Table 32 Global Handheld Ultrasound Market Outlook, By Emergency Medicine (2024-2032) ($MN)
- Table 33 Global Handheld Ultrasound Market Outlook, By Abdominal Imaging (2024-2032) ($MN)
- Table 34 Global Handheld Ultrasound Market Outlook, By Musculoskeletal (MSK) (2024-2032) ($MN)
- Table 35 Global Handheld Ultrasound Market Outlook, By Other Applications (2024-2032) ($MN)
- Table 36 Global Handheld Ultrasound Market Outlook, By End User (2024-2032) ($MN)
- Table 37 Global Handheld Ultrasound Market Outlook, By Hospitals (2024-2032) ($MN)
- Table 38 Global Handheld Ultrasound Market Outlook, By Diagnostic Imaging Centers (2024-2032) ($MN)
- Table 39 Global Handheld Ultrasound Market Outlook, By Home Healthcare (2024-2032) ($MN)
- Table 40 Global Handheld Ultrasound Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
- Table 41 Global Handheld Ultrasound Market Outlook, By Specialty Clinics (2024-2032) ($MN)
- Table 42 Global Handheld Ultrasound Market Outlook, By Maternity Clinics (2024-2032) ($MN)
- Table 43 Global Handheld Ultrasound Market Outlook, By Other End Users (2024-2032) ($MN)
- Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.